Stockreport

Jaguar Health GAAP EPS of -$6.28, revenue of $3.08M [Seeking Alpha]

Jaguar Health, Inc.  (JAGX) 
US:NASDAQ Investor Relations: jaguarhealth.gcs-web.com/investor-overview
PDF Non-GAAP recurring EBITDA for the third quarters of 2025 and 2024 were a net loss of $8.9 million and $8.9 million, respectively. More on Jaguar Health Jaguar Healt [Read more]